Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening lung diseases with high mortality rates, predominantly attributable to acute and severe pulmonary inflammation. Lomerizine (LMZ) is a calcium channel blocker previously used in preventing and treating migrain...

Full description

Bibliographic Details
Main Authors: Yunduan Song, Yusen Gou, Jiameng Gao, Dongxin Chen, Haibo Zhang, Wenjuan Zhao, Feng Qian, Ajing Xu, Yao Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1236469/full
_version_ 1797737404074819584
author Yunduan Song
Yunduan Song
Yusen Gou
Jiameng Gao
Dongxin Chen
Haibo Zhang
Wenjuan Zhao
Feng Qian
Ajing Xu
Yao Shen
author_facet Yunduan Song
Yunduan Song
Yusen Gou
Jiameng Gao
Dongxin Chen
Haibo Zhang
Wenjuan Zhao
Feng Qian
Ajing Xu
Yao Shen
author_sort Yunduan Song
collection DOAJ
description Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening lung diseases with high mortality rates, predominantly attributable to acute and severe pulmonary inflammation. Lomerizine (LMZ) is a calcium channel blocker previously used in preventing and treating migraine. Here, we found that LMZ inhibited inflammatory responses and lung pathological injury by reducing pulmonary edema, neutrophil infiltration and pro-inflammatory cytokine production in lipopolysaccharide (LPS)-induced ALI mice. In vitro experiments, upon treating with LMZ, the expression of interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α was attenuated in macrophages. The phosphorylation of p38 MAPK, ERK1/2, JNK, and NF-κB p65 was inhibited after LMZ treatment. Furthermore, LPS-induced Ca2+ influx was reduced by treating with LMZ, which correlated with inhibition of pro-inflammatory cytokine production. And L-type Ca2+ channel agonist Bay K8644 (BK) could restore cytokine generation. In conclusion, our study demonstrated that LMZ alleviates LPS-induced ALI and is a potential agent for treating ALI/ARDS.
first_indexed 2024-03-12T13:28:12Z
format Article
id doaj.art-30fa29fee8514efd979f555683ccabe1
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-12T13:28:12Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-30fa29fee8514efd979f555683ccabe12023-08-25T01:38:21ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-08-011410.3389/fphar.2023.12364691236469Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influxYunduan Song0Yunduan Song1Yusen Gou2Jiameng Gao3Dongxin Chen4Haibo Zhang5Wenjuan Zhao6Feng Qian7Ajing Xu8Yao Shen9Department of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaDepartment of Clinical Laboratory, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaShanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Clinical Pharmacy, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, ChinaAcute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening lung diseases with high mortality rates, predominantly attributable to acute and severe pulmonary inflammation. Lomerizine (LMZ) is a calcium channel blocker previously used in preventing and treating migraine. Here, we found that LMZ inhibited inflammatory responses and lung pathological injury by reducing pulmonary edema, neutrophil infiltration and pro-inflammatory cytokine production in lipopolysaccharide (LPS)-induced ALI mice. In vitro experiments, upon treating with LMZ, the expression of interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α was attenuated in macrophages. The phosphorylation of p38 MAPK, ERK1/2, JNK, and NF-κB p65 was inhibited after LMZ treatment. Furthermore, LPS-induced Ca2+ influx was reduced by treating with LMZ, which correlated with inhibition of pro-inflammatory cytokine production. And L-type Ca2+ channel agonist Bay K8644 (BK) could restore cytokine generation. In conclusion, our study demonstrated that LMZ alleviates LPS-induced ALI and is a potential agent for treating ALI/ARDS.https://www.frontiersin.org/articles/10.3389/fphar.2023.1236469/fulllomerizineacute lung injurycalciummacrophagecytokineinflammation
spellingShingle Yunduan Song
Yunduan Song
Yusen Gou
Jiameng Gao
Dongxin Chen
Haibo Zhang
Wenjuan Zhao
Feng Qian
Ajing Xu
Yao Shen
Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
Frontiers in Pharmacology
lomerizine
acute lung injury
calcium
macrophage
cytokine
inflammation
title Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
title_full Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
title_fullStr Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
title_full_unstemmed Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
title_short Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx
title_sort lomerizine attenuates lps induced acute lung injury by inhibiting the macrophage activation through reducing ca2 influx
topic lomerizine
acute lung injury
calcium
macrophage
cytokine
inflammation
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1236469/full
work_keys_str_mv AT yunduansong lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT yunduansong lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT yusengou lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT jiamenggao lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT dongxinchen lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT haibozhang lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT wenjuanzhao lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT fengqian lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT ajingxu lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx
AT yaoshen lomerizineattenuateslpsinducedacutelunginjurybyinhibitingthemacrophageactivationthroughreducingca2influx